The global Drugs for Pain Management market is projected to grow from US$ 36340 million in 2024 to US$ 41890 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.4% during the forecast period.

Drugs for Pain Management Market

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

Market Analysis and Insights: Global Drugs for Pain Management Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Drugs for Pain Management market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Drugs for Pain Management, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drugs for Pain Management, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drugs for Pain Management revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Pain Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs for Pain Management revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Drugs for Pain Management Market Report

Report Metric	Details
Report Name	Drugs for Pain Management Market
Accounted market size in 2024	US$ 36340 million
Forecasted market size in 2030	US$ 41890 million
CAGR	2.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Generic Opioid Branded Opioids NSAIDs Others
Segment by Application	Hospitals Drugstores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, Teikoku Seiyaku, Teva, J&J, Assertio Therapeutics, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drugs for Pain Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Pain Management companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Pain Management revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Drugs for Pain Management Market growing?

Ans: The Drugs for Pain Management Market witnessing a CAGR of 2.4 during the forecast period 2025-2030.

What is the Drugs for Pain Management Market size in 2030?

Ans: The Drugs for Pain Management Market size in 2030 will be US$ 41890 million.

Who are the main players in the Drugs for Pain Management Market report?

Ans: The main players in the Drugs for Pain Management Market are GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, Teikoku Seiyaku, Teva, J&J, Assertio Therapeutics, Allergan

What are the Application segmentation covered in the Drugs for Pain Management Market report?

Ans: The Applications covered in the Drugs for Pain Management Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Drugs for Pain Management Market report?

Ans: The Types covered in the Drugs for Pain Management Market report are Generic Opioid, Branded Opioids, NSAIDs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Pain Management Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Generic Opioid

1.2.3 Branded Opioids

1.2.4 NSAIDs

1.2.5 Others

1.3 Market by Application

1.3.1 Global Drugs for Pain Management Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs for Pain Management Market Perspective (2019-2030)

2.2 Global Drugs for Pain Management Growth Trends by Region

2.2.1 Drugs for Pain Management Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drugs for Pain Management Historic Market Size by Region (2019-2024)

2.2.3 Drugs for Pain Management Forecasted Market Size by Region (2025-2030)

2.3 Drugs for Pain Management Market Dynamics

2.3.1 Drugs for Pain Management Industry Trends

2.3.2 Drugs for Pain Management Market Drivers

2.3.3 Drugs for Pain Management Market Challenges

2.3.4 Drugs for Pain Management Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Drugs for Pain Management by Players

3.1.1 Global Drugs for Pain Management Revenue by Players (2019-2024)

3.1.2 Global Drugs for Pain Management Revenue Market Share by Players (2019-2024)

3.2 Global Drugs for Pain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Drugs for Pain Management, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Drugs for Pain Management Market Concentration Ratio

3.4.1 Global Drugs for Pain Management Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Pain Management Revenue in 2023

3.5 Global Key Players of Drugs for Pain Management Head office and Area Served

3.6 Global Key Players of Drugs for Pain Management, Product and Application

3.7 Global Key Players of Drugs for Pain Management, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for Pain Management Breakdown Data by Type

4.1 Global Drugs for Pain Management Historic Market Size by Type (2019-2024)

4.2 Global Drugs for Pain Management Forecasted Market Size by Type (2025-2030)

5 Drugs for Pain Management Breakdown Data by Application

5.1 Global Drugs for Pain Management Historic Market Size by Application (2019-2024)

5.2 Global Drugs for Pain Management Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drugs for Pain Management Market Size (2019-2030)

6.2 North America Drugs for Pain Management Market Size by Type

6.2.1 North America Drugs for Pain Management Market Size by Type (2019-2024)

6.2.2 North America Drugs for Pain Management Market Size by Type (2025-2030)

6.2.3 North America Drugs for Pain Management Market Share by Type (2019-2030)

6.3 North America Drugs for Pain Management Market Size by Application

6.3.1 North America Drugs for Pain Management Market Size by Application (2019-2024)

6.3.2 North America Drugs for Pain Management Market Size by Application (2025-2030)

6.3.3 North America Drugs for Pain Management Market Share by Application (2019-2030)

6.4 North America Drugs for Pain Management Market Size by Country

6.4.1 North America Drugs for Pain Management Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Drugs for Pain Management Market Size by Country (2019-2024)

6.4.3 North America Drugs for Pain Management Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Drugs for Pain Management Market Size (2019-2030)

7.2 Europe Drugs for Pain Management Market Size by Type

7.2.1 Europe Drugs for Pain Management Market Size by Type (2019-2024)

7.2.2 Europe Drugs for Pain Management Market Size by Type (2025-2030)

7.2.3 Europe Drugs for Pain Management Market Share by Type (2019-2030)

7.3 Europe Drugs for Pain Management Market Size by Application

7.3.1 Europe Drugs for Pain Management Market Size by Application (2019-2024)

7.3.2 Europe Drugs for Pain Management Market Size by Application (2025-2030)

7.3.3 Europe Drugs for Pain Management Market Share by Application (2019-2030)

7.4 Europe Drugs for Pain Management Market Size by Country

7.4.1 Europe Drugs for Pain Management Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Drugs for Pain Management Market Size by Country (2019-2024)

7.4.3 Europe Drugs for Pain Management Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Drugs for Pain Management Market Size (2019-2030)

8.2 China Drugs for Pain Management Market Size by Type

8.2.1 China Drugs for Pain Management Market Size by Type (2019-2024)

8.2.2 China Drugs for Pain Management Market Size by Type (2025-2030)

8.2.3 China Drugs for Pain Management Market Share by Type (2019-2030)

8.3 China Drugs for Pain Management Market Size by Application

8.3.1 China Drugs for Pain Management Market Size by Application (2019-2024)

8.3.2 China Drugs for Pain Management Market Size by Application (2025-2030)

8.3.3 China Drugs for Pain Management Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Drugs for Pain Management Market Size (2019-2030)

9.2 Asia Drugs for Pain Management Market Size by Type

9.2.1 Asia Drugs for Pain Management Market Size by Type (2019-2024)

9.2.2 Asia Drugs for Pain Management Market Size by Type (2025-2030)

9.2.3 Asia Drugs for Pain Management Market Share by Type (2019-2030)

9.3 Asia Drugs for Pain Management Market Size by Application

9.3.1 Asia Drugs for Pain Management Market Size by Application (2019-2024)

9.3.2 Asia Drugs for Pain Management Market Size by Application (2025-2030)

9.3.3 Asia Drugs for Pain Management Market Share by Application (2019-2030)

9.4 Asia Drugs for Pain Management Market Size by Region

9.4.1 Asia Drugs for Pain Management Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Drugs for Pain Management Market Size by Region (2019-2024)

9.4.3 Asia Drugs for Pain Management Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Drugs for Pain Management Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Type

10.2.1 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Drugs for Pain Management Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Application

10.3.1 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Drugs for Pain Management Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Country

10.4.1 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Drugs for Pain Management Introduction

11.1.4 GSK Revenue in Drugs for Pain Management Business (2019-2024)

11.1.5 GSK Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Drugs for Pain Management Introduction

11.2.4 Pfizer Revenue in Drugs for Pain Management Business (2019-2024)

11.2.5 Pfizer Recent Developments

11.3 Grunenthal

11.3.1 Grunenthal Company Details

11.3.2 Grunenthal Business Overview

11.3.3 Grunenthal Drugs for Pain Management Introduction

11.3.4 Grunenthal Revenue in Drugs for Pain Management Business (2019-2024)

11.3.5 Grunenthal Recent Developments

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Drugs for Pain Management Introduction

11.4.4 Sanofi Revenue in Drugs for Pain Management Business (2019-2024)

11.4.5 Sanofi Recent Developments

11.5 Bayer

11.5.1 Bayer Company Details

11.5.2 Bayer Business Overview

11.5.3 Bayer Drugs for Pain Management Introduction

11.5.4 Bayer Revenue in Drugs for Pain Management Business (2019-2024)

11.5.5 Bayer Recent Developments

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Drugs for Pain Management Introduction

11.6.4 AstraZeneca Revenue in Drugs for Pain Management Business (2019-2024)

11.6.5 AstraZeneca Recent Developments

11.7 Eli Lilly

11.7.1 Eli Lilly Company Details

11.7.2 Eli Lilly Business Overview

11.7.3 Eli Lilly Drugs for Pain Management Introduction

11.7.4 Eli Lilly Revenue in Drugs for Pain Management Business (2019-2024)

11.7.5 Eli Lilly Recent Developments

11.8 Endo

11.8.1 Endo Company Details

11.8.2 Endo Business Overview

11.8.3 Endo Drugs for Pain Management Introduction

11.8.4 Endo Revenue in Drugs for Pain Management Business (2019-2024)

11.8.5 Endo Recent Developments

11.9 Merck

11.9.1 Merck Company Details

11.9.2 Merck Business Overview

11.9.3 Merck Drugs for Pain Management Introduction

11.9.4 Merck Revenue in Drugs for Pain Management Business (2019-2024)

11.9.5 Merck Recent Developments

11.10 Yunnan Baiyao

11.10.1 Yunnan Baiyao Company Details

11.10.2 Yunnan Baiyao Business Overview

11.10.3 Yunnan Baiyao Drugs for Pain Management Introduction

11.10.4 Yunnan Baiyao Revenue in Drugs for Pain Management Business (2019-2024)

11.10.5 Yunnan Baiyao Recent Developments

11.11 Teikoku Seiyaku

11.11.1 Teikoku Seiyaku Company Details

11.11.2 Teikoku Seiyaku Business Overview

11.11.3 Teikoku Seiyaku Drugs for Pain Management Introduction

11.11.4 Teikoku Seiyaku Revenue in Drugs for Pain Management Business (2019-2024)

11.11.5 Teikoku Seiyaku Recent Developments

11.12 Teva

11.12.1 Teva Company Details

11.12.2 Teva Business Overview

11.12.3 Teva Drugs for Pain Management Introduction

11.12.4 Teva Revenue in Drugs for Pain Management Business (2019-2024)

11.12.5 Teva Recent Developments

11.13 J&J

11.13.1 J&J Company Details

11.13.2 J&J Business Overview

11.13.3 J&J Drugs for Pain Management Introduction

11.13.4 J&J Revenue in Drugs for Pain Management Business (2019-2024)

11.13.5 J&J Recent Developments

11.14 Assertio Therapeutics

11.14.1 Assertio Therapeutics Company Details

11.14.2 Assertio Therapeutics Business Overview

11.14.3 Assertio Therapeutics Drugs for Pain Management Introduction

11.14.4 Assertio Therapeutics Revenue in Drugs for Pain Management Business (2019-2024)

11.14.5 Assertio Therapeutics Recent Developments

11.15 Allergan

11.15.1 Allergan Company Details

11.15.2 Allergan Business Overview

11.15.3 Allergan Drugs for Pain Management Introduction

11.15.4 Allergan Revenue in Drugs for Pain Management Business (2019-2024)

11.15.5 Allergan Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Assertio Therapeutics

Allergan plc

List of Tables

Table 1. Global Drugs for Pain Management Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Generic Opioid

Table 3. Key Players of Branded Opioids

Table 4. Key Players of NSAIDs

Table 5. Key Players of Others

Table 6. Global Drugs for Pain Management Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Drugs for Pain Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Drugs for Pain Management Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Drugs for Pain Management Market Share by Region (2019-2024)

Table 10. Global Drugs for Pain Management Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Drugs for Pain Management Market Share by Region (2025-2030)

Table 12. Drugs for Pain Management Market Trends

Table 13. Drugs for Pain Management Market Drivers

Table 14. Drugs for Pain Management Market Challenges

Table 15. Drugs for Pain Management Market Restraints

Table 16. Global Drugs for Pain Management Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Drugs for Pain Management Revenue Share by Players (2019-2024)

Table 18. Global Top Drugs for Pain Management by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Pain Management as of 2023)

Table 19. Global Drugs for Pain Management Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Drugs for Pain Management Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Drugs for Pain Management, Headquarters and Area Served

Table 22. Global Key Players of Drugs for Pain Management, Product and Application

Table 23. Global Key Players of Drugs for Pain Management, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Drugs for Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Drugs for Pain Management Revenue Market Share by Type (2019-2024)

Table 27. Global Drugs for Pain Management Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Drugs for Pain Management Revenue Market Share by Type (2025-2030)

Table 29. Global Drugs for Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Drugs for Pain Management Revenue Share by Application (2019-2024)

Table 31. Global Drugs for Pain Management Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Drugs for Pain Management Revenue Share by Application (2025-2030)

Table 33. North America Drugs for Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Drugs for Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Drugs for Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Drugs for Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Drugs for Pain Management Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Drugs for Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Drugs for Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Drugs for Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Drugs for Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Drugs for Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Drugs for Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Drugs for Pain Management Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Drugs for Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Drugs for Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Drugs for Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Drugs for Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Drugs for Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Drugs for Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Drugs for Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Drugs for Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Drugs for Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Drugs for Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Drugs for Pain Management Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Drugs for Pain Management Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Drugs for Pain Management Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Drugs for Pain Management Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Drugs for Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 65. GSK Company Details

Table 66. GSK Business Overview

Table 67. GSK Drugs for Pain Management Product

Table 68. GSK Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 69. GSK Recent Developments

Table 70. Pfizer Company Details

Table 71. Pfizer Business Overview

Table 72. Pfizer Drugs for Pain Management Product

Table 73. Pfizer Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 74. Pfizer Recent Developments

Table 75. Grunenthal Company Details

Table 76. Grunenthal Business Overview

Table 77. Grunenthal Drugs for Pain Management Product

Table 78. Grunenthal Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 79. Grunenthal Recent Developments

Table 80. Sanofi Company Details

Table 81. Sanofi Business Overview

Table 82. Sanofi Drugs for Pain Management Product

Table 83. Sanofi Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 84. Sanofi Recent Developments

Table 85. Bayer Company Details

Table 86. Bayer Business Overview

Table 87. Bayer Drugs for Pain Management Product

Table 88. Bayer Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 89. Bayer Recent Developments

Table 90. AstraZeneca Company Details

Table 91. AstraZeneca Business Overview

Table 92. AstraZeneca Drugs for Pain Management Product

Table 93. AstraZeneca Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 94. AstraZeneca Recent Developments

Table 95. Eli Lilly Company Details

Table 96. Eli Lilly Business Overview

Table 97. Eli Lilly Drugs for Pain Management Product

Table 98. Eli Lilly Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 99. Eli Lilly Recent Developments

Table 100. Endo Company Details

Table 101. Endo Business Overview

Table 102. Endo Drugs for Pain Management Product

Table 103. Endo Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 104. Endo Recent Developments

Table 105. Merck Company Details

Table 106. Merck Business Overview

Table 107. Merck Drugs for Pain Management Product

Table 108. Merck Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 109. Merck Recent Developments

Table 110. Yunnan Baiyao Company Details

Table 111. Yunnan Baiyao Business Overview

Table 112. Yunnan Baiyao Drugs for Pain Management Product

Table 113. Yunnan Baiyao Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 114. Yunnan Baiyao Recent Developments

Table 115. Teikoku Seiyaku Company Details

Table 116. Teikoku Seiyaku Business Overview

Table 117. Teikoku Seiyaku Drugs for Pain Management Product

Table 118. Teikoku Seiyaku Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 119. Teikoku Seiyaku Recent Developments

Table 120. Teva Company Details

Table 121. Teva Business Overview

Table 122. Teva Drugs for Pain Management Product

Table 123. Teva Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 124. Teva Recent Developments

Table 125. J&J Company Details

Table 126. J&J Business Overview

Table 127. J&J Drugs for Pain Management Product

Table 128. J&J Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 129. J&J Recent Developments

Table 130. Assertio Therapeutics Company Details

Table 131. Assertio Therapeutics Business Overview

Table 132. Assertio Therapeutics Drugs for Pain Management Product

Table 133. Assertio Therapeutics Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 134. Assertio Therapeutics Recent Developments

Table 135. Allergan Company Details

Table 136. Allergan Business Overview

Table 137. Allergan Drugs for Pain Management Product

Table 138. Allergan Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 139. Allergan Recent Developments

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drugs for Pain Management Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Drugs for Pain Management Market Share by Type: 2023 VS 2030

Figure 3. Generic Opioid Features

Figure 4. Branded Opioids Features

Figure 5. NSAIDs Features

Figure 6. Others Features

Figure 7. Global Drugs for Pain Management Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Drugs for Pain Management Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Drugstores Case Studies

Figure 11. Others Case Studies

Figure 12. Drugs for Pain Management Report Years Considered

Figure 13. Global Drugs for Pain Management Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Drugs for Pain Management Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Drugs for Pain Management Market Share by Region: 2023 VS 2030

Figure 16. Global Drugs for Pain Management Market Share by Players in 2023

Figure 17. Global Top Drugs for Pain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Pain Management as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Drugs for Pain Management Revenue in 2023

Figure 19. North America Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Drugs for Pain Management Market Share by Type (2019-2030)

Figure 21. North America Drugs for Pain Management Market Share by Application (2019-2030)

Figure 22. North America Drugs for Pain Management Market Share by Country (2019-2030)

Figure 23. United States Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Drugs for Pain Management Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Drugs for Pain Management Market Share by Type (2019-2030)

Figure 27. Europe Drugs for Pain Management Market Share by Application (2019-2030)

Figure 28. Europe Drugs for Pain Management Market Share by Country (2019-2030)

Figure 29. Germany Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Drugs for Pain Management Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Drugs for Pain Management Market Share by Type (2019-2030)

Figure 37. China Drugs for Pain Management Market Share by Application (2019-2030)

Figure 38. Asia Drugs for Pain Management Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Drugs for Pain Management Market Share by Type (2019-2030)

Figure 40. Asia Drugs for Pain Management Market Share by Application (2019-2030)

Figure 41. Asia Drugs for Pain Management Market Share by Region (2019-2030)

Figure 42. Japan Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Drugs for Pain Management Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Drugs for Pain Management Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Drugs for Pain Management Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Drugs for Pain Management Market Share by Country (2019-2030)

Figure 52. Brazil Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GSK Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 59. Pfizer Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 60. Grunenthal Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 61. Sanofi Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 62. Bayer Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 63. AstraZeneca Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 64. Eli Lilly Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 65. Endo Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 66. Merck Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 67. Yunnan Baiyao Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 68. Teikoku Seiyaku Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 69. Teva Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 70. J&J Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 71. Assertio Therapeutics Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 72. Allergan Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions